ASSESSING THE RISK OF CARDIOVASCULAR DISEASE DURING THE CLIMACTERIC PERIOD OF WOMEN
Main Article Content
Abstract
The article describes the mechanisms of assessing the risk of cardiovascular disease in women during the climacteric period, its origin and incidence.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
Ergasheva M.T. Khaidarov S.N. Evaluation of endothelial dysfunction in patients with metabolic syndrome.
Аметов А.С., Демидова И.Ю., Целиковская А.Л. Ожирение и сердечно-сосудистые заболевания. Тер архив 2001; 8: 66-9.
Оганов Р.Г., Перова Н.В., Метельская В.А Абдоминальное ожирение у больных артериальной гипертонией: атерогенные нарушения в системе транспорта липидов и обмена углеводов. РКЖ 2001; 31(5): 16-20.
Kannel WB, Cuppels LA, Ramaswami R, et al. M. Regional obesity and risk of cardiovascular disease; the Framingham study. J Clin Epidemiol 1991; 44(2): 183-90.
Репина М.А. Менопаузальный метаболический синдром и ожирение. Ж акуш жен бол 2003; 3: 75-84.
Kuh D, Langenberg C, Hardy R, et al. Cardiovascular risk at age 53 years in relation to the menopause transition and use of hormone replacement therapy: a prospective British birth cohort study. BJOG 2005; 112(4): 476-85.
Spencer CP, Godsland IF, Stevenson JC. Is there a menopausal metabolic syndrome. Gynecol Endocrinol 1997; 11(5): 341-55.